Atea Pharmaceuticals is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Biotechnology

Atea Pharmaceuticals

Atea Pharmaceuticals' headquarters in MA, United States

Jean-Pierre Sommadossi

Andrea Corcoran

Jayanthi Wolf

Janet Hammond

Adel Moussa

John Vavricka

Arantxa Horga

Bruce Belanger

Jerome Adams

Franklin Berger

Barbara Duncan

Bruce Polsky

Polly A. Murphy

Bruno Lucidi

The Leadership Team at Atea Pharmaceuticals is responsible for setting the strategic direction and overarching vision of the company as it develops innovative antiviral treatments. This multidisciplinary team, comprised of executives from various functional areas such as chemistry, regulatory affairs, clinical operations, and finance, collaborates to guide research, manage resources, ensure compliance, and ultimately drive the company's mission to address significant medical needs. Their collective expertise facilitates informed decision-making and fosters a culture of innovation within the organization.

Leadership Team

The Clinical Development team at Atea Pharmaceuticals is responsible for designing, implementing, and managing clinical trials to evaluate the safety and efficacy of novel antiviral treatments. This multidisciplinary team, comprising experts in biostatistics, clinical operations, and both preclinical and early-stage development, collaborates to ensure that all clinical activities align with regulatory requirements and scientific rigor, ultimately advancing innovative therapies from concept to the clinic.

Clinical Development

��

Atea Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development

Offices

��������

Atea Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development

Offices

Related companies

��